Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Business & Regulation

Business & Regulation Business Practice

Roe v. Wade and the Future of Medical Abortions in the US

| Maryam Mahdi | 2 min read

How will pharma companies navigate America’s new abortion laws?

Business & Regulation Trends & Forecasts

Post-Conference Reflections

| Angus Stewart | 9 min read

The International Society for Cell & Gene Therapy convened in person for the first time in two years. We spoke to an attendee for an insight

Business & Regulation Business Practice

Champions of Cell and Gene Therapy

| Angus Stewart | 7 min read

In our third C+G Champions installment, we ask industry leaders in the cell and gene field about accessibility for the many

Business & Regulation Standards & Regulation

Acting on the Drug Supply Chain Security Act

| Shabbir Imber Safdar | 8 min read

The US drug supply chain is not immune to counterfeits – but there’s a law for that. Here’s how it has been used so far.

Business & Regulation Standards & Regulation

How to Avoid FDA Warning Letters

| Stephanie Sutton | 3 min read

It’s relatively simple: Follow cGMP, keep your facilities clean, keep vermin out, and don’t sell unapproved products…

Business & Regulation Trends & Forecasts

Chasing Harmony

| Angus Stewart | 8 min read

An inside view of the pharmaceutical industry in China. Where has it been, where does it stand, and where is it going?

Business & Regulation COVID-19

From COVID-19 to Monkeypox

| Stephanie Sutton

It’s been a busy time for infectious disease vaccine news in Europe.

Business & Regulation Profession

The Best of Both Worlds

| Viktoria Gessner, Angelino Doppiu | 4 min read

Academia-industry collaboration doesn’t have to be difficult; we just need to appreciate one another’s differences.

Business & Regulation Profession

COVID-19: The Lessons We Have Learned

| Stephanie Sutton | 8 min read

What are the biggest lessons that the pharma industry has learned from the COVID-19 pandemic?

Business & Regulation Business Practice

Words With the Fearless Leader

| Angus Stewart | 6 min read

Where did DNDi come from – and where is it going? We ask the nonprofit organization’s chief for a rundown

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register